Regulatory Automation Indegene launched NEXT Medical Writing Automation in 2025, an AI powered platform that accelerates regulatory documentation while maintaining compliance. This creates opportunities to offer speed to market and cost efficiency to Regulatory Affairs and Clinical teams, across regulatory submissions and documentation workflows.

Data Driven Recruitment A strategic Datavant partnership strengthens patient recruitment capabilities for clinical trials, with a focus on rare diseases and complex studies. This opens sales opportunities in site selection, enrollment planning, and data informed recruitment programs for sponsors seeking shorter trial timelines.

Acquisition Powered Growth Recent acquisitions of Warn & Co and BioPharm International, along with the appointment of a Head of the Integrated Consulting Practice, signal expanded end to end transformation capabilities. This positions Indegene to win large cross functional programs spanning clinical, medical, and commercial functions.

Trusted Partner Network Serving 20 of the world's top biopharma companies across the value chain demonstrates deep credibility. Indegene markets itself as a digital first life sciences partner and emphasizes Practitioner Level Confidence, making it a strong option for enterprise wide modernization from strategy to execution.

Global Delivery Scale With 25 years of experience and a global team of roughly five to ten thousand employees, Indegene offers scalable global delivery for multi country commercialization programs. Its technology oriented approach includes tools such as Google Analytics 4 and Python, enabling scalable data driven programs across markets.